Market By Product, Test Type, Technology And Geography | Forecast 2019-2027
A Triton Market Research report states the newborn screening market in Europe to grow with a CAGR of 13.42% during the forecasting years 2019 to 2027.
The countries analyzed in the European newborn screening market are:
• United Kingdom
• Germany
• France
• Spain
• Italy
• Russia
• Rest of Europe
Report scope can be customized per your requirements. Request For Customization
The rise of the newborn screening market in the United Kingdom is backed by the support from the government for newborn screening and the rise in the occurrence of sickle cell diseases in newborns. According to the National Health Service Organization (England, UK), England’s screening programs are leading the world. Additionally, the UK government has enthusiastically been supporting various programs that support newborn screening. The government has introduced three programs named NHS (National Health Service) Newborn and Infant Physical Examination Programme, NHS Newborn Blood Spot Screening Programme and the NHS Newborn Hearing Screening Programme.
The NHS Newborn Hearing Screening Programme aims to offer a hearing screening test for babies during the first few weeks of their lives to detect who are born with hearing loss. As per the NHS Organization, around 1-2 babies in every 1000 are born with permanent hearing loss in one or both ears, which in turn, would generate the need for newborn screening considering the rising need to detect diseases such as hearing loss, critical congenital heart disease (CCHD), etc. Furthermore, the rising prevalence of sickle cell diseases in newborn babies positively influences the growth of the newborn screening market in the United Kingdom.
The rise of the newborn screening market in Germany is backed by government projects supporting technological advancement in the field of newborn screening and mandatory government regulations for newborn screening. According to the European Commission, a cooperation project between clinics in Poland and Germany has led to advances in newborn screening for metabolic diseases in both the countries with an aim to bring potential health benefits to thousands of newborn babies every year. With this project, countries are now able to diagnose more diseases. In addition, due to the purchase of new and advanced medical equipment, the screening lab in Germany and Poland can now detect 14 diseases which are very common in newborn babies. As a result of it, adoption for newborn screening would rise, considering the technological advancements in newborn screening techniques.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE NEWBORN SCREENING MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. DEMAND FOR NEWBORN SCREENING INSTRUMENTS IS
RISING STEADILY
2.2.2. GROWTH IN DRY BLOOD SPOT TEST
2.2.3. TECHNIQUES USED IN NEWBORN SCREENING TESTS
2.3. EVOLUTION & TRANSITION OF NEWBORN
SCREENING
2.4. PORTER’S FIVE FORCE ANALYSIS
2.4.1. THREAT OF NEW ENTRANTS
2.4.2. THREAT OF SUBSTITUTE
2.4.3. BARGAINING POWER OF SUPPLIERS
2.4.4. BARGAINING POWER OF BUYERS
2.4.5. THREAT OF COMPETITIVE RIVALRY
2.5. KEY IMPACT ANALYSIS
2.5.1. RELIABILITY
2.5.2. COST
2.5.3. AVAILABILITY
2.5.4. TECHNOLOGICAL ADVANCEMENT
2.6. MARKET ATTRACTIVENESS INDEX
2.7. VENDOR SCORECARD
2.8. INDUSTRY COMPONENTS
2.8.1. RAW MATERIAL SUPPLIERS
2.8.2. MANUFACTURERS
2.8.3. DISTRIBUTORS
2.8.4. END-USERS
2.9. REGULATORY FRAMEWORK
2.10. INDUSTRY PLAYER POSITIONING
2.11. KEY MARKET STRATEGIES
2.11.1. PRODUCT LAUNCH
2.12. MARKET DRIVERS
2.12.1. INCREASE IN OCCURRENCES OF NEWBORN DISEASES
2.12.2. GROWING NUMBER OF INFANTS WITH BIRTH DEFECT
2.12.3. BACKING OF GOVERNMENT TOWARDS NEWBORN CHILD
HEALTH
2.12.4. RISING AWARENESS FOR PEDIATRIC CONGENITAL
HEART DISEASE
2.13. MARKET RESTRAINTS
2.13.1. SOCIO-ECONOMIC HURDLES IN THE IMPLEMENTATION
OF NEWBORN CHILD SCREENING
2.14. MARKET OPPORTUNITIES
2.14.1. NEWBORN SCREENING HELPS IN EARLY
IDENTIFICATION AND MANAGEMENT OF AFFECTED NEWBORNS
2.14.2. TECHNOLOGICAL ADVANCEMENTS IN NEWBORN
SCREENING
2.14.3. INCREASE IN NUMBER OF PREGNANT WOMEN WITH
ADVANCED MATERNAL AGE
2.15. MARKET CHALLENGES
2.15.1. DEARTH OF SKILLED PROFESSIONAL IN HEALTHCARE
INDUSTRY
2.15.2. MAINTENANCE OF EQUIPMENT IN HOSPITAL
3. NEWBORN SCREENING MARKET OUTLOOK - BY PRODUCT
3.1. NEWBORN SCREENING INSTRUMENTS
3.2. NEWBORN SCREENING REAGENTS & ASSAY KITS
4. NEWBORN SCREENING MARKET OUTLOOK - BY TEST
TYPE
4.1. HEARING SCREEN TEST
4.2. CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST
4.3. DRY BLOOD SPOT TEST
5. NEWBORN SCREENING MARKET OUTLOOK - BY
TECHNOLOGY
5.1. TANDEM MASS SPECTROMETRY
5.2. PULSE OXIMETRY
5.3. ENZYME-BASED ASSAYS
5.4. DNA-BASED ASSAYS
5.5. ELECTROPHORESIS
5.6. OTHERS
6. NEWBORN SCREENING MARKET - REGIONAL OUTLOOK
6.1. UNITED KINGDOM
6.2. GERMANY
6.3. FRANCE
6.4. SPAIN
6.5. ITALY
6.6. RUSSIA
6.7. REST OF EUROPE
7. COMPETITIVE LANDSCAPE
7.1. SCIEX
7.2. BIOTEK INSTRUMENTS, INC.
7.3. BIO-RAD LABORATORIES, INC.
7.4. CARDINAL HEALTH, INC.
7.5. GE HEALTHCARE LIMITED
7.6. AGILENT TECHNOLOGIES, INC.
7.7. MASIMO CORPORATION
7.8. NATUS MEDICAL, INCORPORATED
7.9. MEDTRONIC PLC
7.10. THERMO FISHER SCIENTIFIC, INC.
7.11. NEOGEN LABS PVT. LTD.
7.12. PERKINELMER, INC.
7.13. ZENTECH S.A.
7.14. WATERS CORPORATION
7.15. TRIVITRON HEALTHCARE
8. METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY
TABLE 1: EUROPE NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $
MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: LIST OF PRODUCT LAUNCHES
TABLE 6: EUROPE NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $
MILLION)
TABLE 7: EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $
MILLION)
TABLE 8: EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $
MILLION)
TABLE 9: EUROPE NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $
MILLION)
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: KEY BUYING IMPACT ANALYSIS
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: INDUSTRY PLAYER POSITIONING IN 2018 (IN %)
FIGURE 5: FERTILITY RATE (AVERAGE BIRTHS PER WOMAN IN %) IN 2017
FIGURE 6: EUROPE NEWBORN SCREENING MARKET, BY NEWBORN SCREENING
INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 7: EUROPE NEWBORN SCREENING MARKET, BY NEWBORN SCREENING REAGENTS
& ASSAY KITS, 2019-2027 (IN $ MILLION)
FIGURE 8: EUROPE NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST,
2019-2027 (IN $ MILLION)
FIGURE 9: EUROPE NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL HEART
DISEASE (CCHD) TEST, 2019-2027 (IN $ MILLION)
FIGURE 10: EUROPE NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT TEST,
2019-2027 (IN $ MILLION)
FIGURE 11: EUROPE NEWBORN SCREENING MARKET, BY TANDEM MASS SPECTROMETRY,
2019-2027 (IN $ MILLION)
FIGURE 12: EUROPE NEWBORN SCREENING MARKET, BY PULSE OXIMETRY, 2019-2027
(IN $ MILLION)
FIGURE 13: EUROPE NEWBORN SCREENING MARKET, BY ENZYME-BASED ASSAY,
2019-2027 (IN $ MILLION)
FIGURE 14: EUROPE NEWBORN SCREENING MARKET, BY DNA-BASED ASSAYS,
2019-2027 (IN $ MILLION)
FIGURE 15: EUROPE NEWBORN SCREENING MARKET, BY ELECTROPHORESIS,
2019-2027 (IN $ MILLION)
FIGURE 16: EUROPE NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027 (IN $
MILLION)
FIGURE 17: EUROPE NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018 &
2027 (IN %)
FIGURE 18: UNITED KINGDOM NEWBORN SCREENING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 19: GERMANY NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 20: FRANCE NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 21: SPAIN NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 22: ITALY NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 23: RUSSIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 24: REST OF EUROPE NEWBORN SCREENING MARKET, 2019-2027 (IN $
MILLION)